CLB
Core Laboratories Inc.$10.11 −0.11 (−1.03%)
Oct 27 4:00 PM ET · prev $10.22
Market cap
$431.3M
Small cap
Median target
🔒 Subscribers only
1 year
−40.0%
from $16.86 · Oct 27
30 days
+0.8%
from $10.03
52-week range
$9.40–19.67
−49% from high · low Oct 22
Avg volume 20D
627.8K
shares / day
Short interest
🔒 Subscribers only
Insider net
+$53.9K
1 buyer · 0 sellers · 12 mo
New fund stakes
1
Q2 2026 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read BULLISH 1 report · 90 days
Balance 0 bearish · 1 bullish oldest → newest, height = score
Avg score
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- B Jul 31 1 insider buy $53.9K at $10.78
Signal stack
Where each data set points today.
- InsidersBULLISH
1 insider bought $53.9K at an average $10.78. No open-market sales. Price is 6% below their cost.
- InstitutionsMIXED
Q2 2026: 16 added (1 new), 11 trimmed or exited. Largest new: Schroder Investment Management Group $16.9M.
- TrendDOWNTREND
9% below its 50-day average. New closing low $9.40 on Oct 22.
Who's buying
13F· Q2 20261
new positions
0
exits
$16.9M
in new stakes
| Fund | Move | Value |
|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | NEW | $16.9M |
| GENDELL JEFFREY L | ADD | $12.7M |
| MORGAN STANLEY | ADD | $7.6M |
| Fisher Asset Management, LLC | TRIM | $5.2M |
| CITADEL ADVISORS LLC | DOUBLED | $4.3M |
| D. E. Shaw & Co., Inc. | DOUBLED | $2.9M |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | ADD | $2.7M |
| Russell Investments Group, Ltd. | ADD | $2.3M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action Jul 2025Recent actions
| Date | Firm | Rating |
|---|---|---|
| Jul 16, 2025 | Stifel MAINTAIN | Hold |
| May 13, 2025 | Citigroup MAINTAIN | Neutral |
| Apr 15, 2025 | Stifel MAINTAIN | Hold |
| Mar 12, 2025 | Citigroup UPGRADE | Neutral |
| Feb 20, 2025 | Citigroup MAINTAIN | Sell |
| Oct 31, 2024 | Citigroup MAINTAIN | Sell |
Insider ledger
Form 4$53.9K
bought · 1 insider
$0
sold · 0 insiders
−6.2%
vs their $10.78 cost
| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 1, 2026 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | EXERCISE | 700 sh |
| Oct 1, 2026 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | TAX W/H | $2.7K |
| Oct 1, 2026 | Teo Sow Hang CAO & Treasurer | EXERCISE | 250 sh |
| Oct 1, 2026 | Teo Sow Hang CAO & Treasurer | TAX W/H | $966.24 |
| Aug 1, 2026 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | TAX W/H | $1.1K |
| Aug 1, 2026 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | EXERCISE | 250 sh |
| Aug 1, 2026 | Teo Sow Hang CAO & Treasurer | TAX W/H | $1.1K |
| Aug 1, 2026 | Teo Sow Hang CAO & Treasurer | EXERCISE | 240 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | $0.17 | $0.15–$0.19 | +2.0% | $133.3M |
| Current FY | $0.51 | $0.49–$0.52 | +10.9% | $511.9M |
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 Insider
Tattoli Mark Damian acquired via exercise 700 shares
SVP, Gen Counsel & Secretary
Oct 1, 2026 Insider
Tattoli Mark Damian surrendered for taxes 276 shares
SVP, Gen Counsel & Secretary @ $9.76 ($2.7K)
Oct 1, 2026 Insider
Teo Sow Hang acquired via exercise 250 shares
CAO & Treasurer
Sep 15, 2026 Short interest report
Aug 4, 2026 SEC Short Interest: CLB up 7% to 4.4M shares
Settlement 2026-09-15 | Days to cover: 10.24 | ≈9.55% of shares outstanding (est.)
Core Laboratories Chairman and CEO Bruno Lawrence made an open-market purchase of 5,000 shares for $54K at $10.78, the…
INSIDER-BUY — Impact 4/10
Jun 30, 2026 Inst.
SCHRODER INVESTMENT MANAGEMENT GROUP — NEW
1,543,638 shares ($16.9M)
Jun 30, 2026 Inst.
GENDELL JEFFREY L — ADD
1,090,973 shares ($12.7M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 15, 2026
Short interest
Short Interest: CLB up 7% to 4.4M shares
Settlement 2026-09-15 | Days to cover: 10.24 | ≈9.55% of shares outstanding (est.)
Jul 15, 2026
Short interest
Short Interest: CLB down 33% to 4.0M shares
Settlement 2026-07-15 | Days to cover: 2.49 | ≈8.73% of shares outstanding (est.)
Apr 29, 2026
Earnings date
CLB Q1 2026 Earnings After Market Close — 2026-04-29
Feb 6, 2026
Short interest
FTD: CLB — 37,011 shares ($0.7M) failed to deliver
Settlement: 20260206, Price: $18.78, FTD Value: $695,066.58, CORE LABORATORIES INC COM (DE)
SecBot reports
1 filing · 1 bullish · 0 bearishAll CLB filing & press-release reports (1)
- INSIDER-BUY reportAug 4, 2026